These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15322758)

  • 1. [Pharmaceutical treatment of stress incontinence. New approaches via a direct effect of duloxetine on Onuf's nucleus].
    Jost WH; Marsalek P; Manning M; Jünemann KP
    Urologe A; 2004 Oct; 43(10):1249-53. PubMed ID: 15322758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence.
    Thor KB
    Urology; 2003 Oct; 62(4 Suppl 1):3-9. PubMed ID: 14550831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacotherapy of stress incontinence].
    Jost WH; Marsalek P; Michel MC
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2337-42. PubMed ID: 16231235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Duloxetine. A new preparation for patients with urinary incontinence].
    Walter S
    Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting serotonin and norepinephrine receptors in stress urinary incontinence.
    Thor KB
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S38-52. PubMed ID: 15302566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of duloxetine in the treatment of stress urinary incontinence].
    Rouprêt M; Richard F; Chartier-Kastler E
    Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).
    Alberti C
    G Chir; 2013; 34(7-8):189-94. PubMed ID: 24091172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of serotonin and noradrenaline in stress urinary incontinence.
    Michel MC; Peters SL
    BJU Int; 2004 Jul; 94 Suppl 1():23-30. PubMed ID: 15139860
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of 5-HT receptors in treatment of overactive bladder.
    Khaled SM; Elhilali M
    Drugs Today (Barc); 2003 Aug; 39(8):599-607. PubMed ID: 14566383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine for management of stress urinary incontinence.
    Guay DR
    Am J Geriatr Pharmacother; 2005 Mar; 3(1):25-38. PubMed ID: 16089245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system control of the lower urinary tract: new pharmacological approaches to stress urinary incontinence in women.
    Thor KB; Donatucci C
    J Urol; 2004 Jul; 172(1):27-33. PubMed ID: 15201731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.